GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Uniphar PLC (DUB:UPR) » Definitions » 3-Year RORE %

Uniphar (DUB:UPR) 3-Year RORE % : -3.29% (As of Jun. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Uniphar 3-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Uniphar's 3-Year RORE % for the quarter that ended in Jun. 2024 was -3.29%.

The industry rank for Uniphar's 3-Year RORE % or its related term are showing as below:

DUB:UPR's 3-Year RORE % is ranked worse than
54.64% of 97 companies
in the Medical Distribution industry
Industry Median: -0.23 vs DUB:UPR: -3.29

Uniphar 3-Year RORE % Historical Data

The historical data trend for Uniphar's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Uniphar 3-Year RORE % Chart

Uniphar Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
3-Year RORE %
Get a 7-Day Free Trial - - 15.73 15.02 -3.08

Uniphar Semi-Annual Data
Dec16 Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.00 15.02 12.01 -3.08 -3.29

Competitive Comparison of Uniphar's 3-Year RORE %

For the Medical Distribution subindustry, Uniphar's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Uniphar's 3-Year RORE % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Uniphar's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Uniphar's 3-Year RORE % falls into.



Uniphar 3-Year RORE % Calculation

Uniphar's 3-Year RORE % for the quarter that ended in Jun. 2024 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( 0.165-0.18 )/( 0.508-0.052 )
=-0.015/0.456
=-3.29 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Jun. 2024 and 3-year before.


Uniphar  (DUB:UPR) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Uniphar 3-Year RORE % Related Terms

Thank you for viewing the detailed overview of Uniphar's 3-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Uniphar Business Description

Traded in Other Exchanges
Address
4045 Kingswood Road, Citywest Business Park, Dublin, IRL, D24 V06K
Uniphar PLC is a diversified healthcare service organization with activities in Ireland, the UK, and the Benelux. The business activities of the group function through the Commercial & Clinical division, which provides outsourced services, specifically sales, marketing, and multichannel account management to pharmaco-medical manufacturers, and distribution and support services to medical device manufacturers. The product Access division consists of two service offerings, being: On-Demand Access and Exclusive Access. Supply Chain & Retail division provides both pre-wholesale distribution and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and vEterinary surgeons in Ireland.

Uniphar Headlines

No Headlines